Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    393 - I am curious to know how/why the product ColdFX can make DTC claims such as 'clinically proven' and '#1 doctor recommended'. Would this not fall under the NHP regulations of PAAB?

    DTCA/I, consumer secondary audience
    1
    1
    57
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Thanks for your question. There is an important distinction to make here with regards to the Canadian regulatory landscape for drug advertising. The PAAB code applies to health care product advertising which is directed to healthcare professionals. Natural Health Products (NHPs) are indeed included in the PAAB code’s definition of health care products (PAAB s1 & 11); however, DTC for NHPs falls neither within the scope of the PAAB code nor within the scope of PAAB review activities. As a courtesy, concerns relating to NHP DTC advertising may be directed to Advertising Standards Canada, MIJO, or Health Canada. The scope of the PAAB includes promotional healthcare product communication for prescription, non-prescription, biological and natural health products to health care professionals in all media. PAAB also provides advisory comments on direct-to-consumer materials for prescription drugs. You can learn more about the PAAB vision, mission, mandate, and scope at the following link: http://www.paab.ca/mission.htm

      1 Reply Last reply Reply Quote 0
      • First post
        Last post